Form D — Fedora Pharmaceuticals Inc.
0001576423-25-000004 · filed Jun 6, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Reported offering amount
- $7,239,326
- Reported amount sold
- $895,076
- Minimum investment
- $69,592
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Fedora Pharmaceuticals Inc.
- CIK
- 1576423
- Entity
- Corporation
- Jurisdiction
- ALBERTA, CANADA
- Year incorporated
- —
- Address
- 11629 105 AVENUE NW
EDMONTON, A0 T5H 092 - Phone
- (708) 761-0561
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Christopher Micetich · Executive OfficerEdmonton, A0 Find on LinkedIn ↗
-
Leonard Post · DirectorEdmonton, A0 Find on LinkedIn ↗
-
Sarat Maharaj · DirectorEdmonton, A0 Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗